240 related articles for article (PubMed ID: 6334939)
1. The pathogenesis of arthritis in Lyme disease: humoral immune responses and the role of intra-articular immune complexes.
Hardin JA; Steere AC; Malawista SE
Yale J Biol Med; 1984; 57(4):589-93. PubMed ID: 6334939
[TBL] [Abstract][Full Text] [Related]
2. Isolation and characterization of circulating immune complexes in patients with rheumatoid arthritis.
Perego R; Vezzoli S; Manfredi W; Bigi G; Procaccia S
Boll Ist Sieroter Milan; 1983 Nov; 62(5):462-8. PubMed ID: 6608359
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of complement components in polyethylene glycol precipitated immune complexes from patients with ovarian cancer and patients with rheumatoid arthritis.
Mooney NA; Hay FC; Poulton TA
Clin Exp Immunol; 1983 Jun; 52(3):561-8. PubMed ID: 6603297
[TBL] [Abstract][Full Text] [Related]
4. [Determination of circulating immune complexes in rheumatoid arthritis: comparison of 2 immunoenzyme methods].
Bernardoni R; Soffritti E; Pelizzola D; Pazzi A; Accardo G
Riv Emoter Immunoematol; 1985; 32(1):58-68. PubMed ID: 3909362
[No Abstract] [Full Text] [Related]
5. Immune complexes and the evolution of Lyme arthritis. Dissemination and localization of abnormal C1q binding activity.
Hardin JA; Steere AC; Malawista SE
N Engl J Med; 1979 Dec; 301(25):1358-63. PubMed ID: 503166
[TBL] [Abstract][Full Text] [Related]
6. Circulating complement breakdown products in patients with rheumatoid arthritis. Correlation between plasma C3d, circulating immune complexes, and clinical activity.
Nydegger UE; Zubler RH; Gabay R; Joliat G; Karagevrekis CH; Lambert PH; Miescher PA
J Clin Invest; 1977 May; 59(5):862-8. PubMed ID: 853126
[TBL] [Abstract][Full Text] [Related]
7. The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease.
Bourke BE; Moss IK; Mumford P; Horsfall A; Maini RN
Clin Exp Immunol; 1982 Jun; 48(3):726-32. PubMed ID: 6981475
[TBL] [Abstract][Full Text] [Related]
8. Immune complexes and complement in rheumatoid arthritis.
Lambert PH; Casali P; Nydegger U
Bull Schweiz Akad Med Wiss; 1979 Sep; 35(4-6):301-15. PubMed ID: 534786
[TBL] [Abstract][Full Text] [Related]
9. Complement activation in seropositive and seronegative rheumatoid arthritis. 125I-C1q binding capacity and complement breakdown products in serum and synovial fluid.
Lambert PH; Nydegger UE; Perrin LH; McCormic J; Fehr K; Miescher PA
Rheumatology; 1975; 6():52-9. PubMed ID: 1202608
[TBL] [Abstract][Full Text] [Related]
10. IgA containing immune complexes in rheumatoid vasculitis and in active rheumatoid disease.
Westedt ML; Daha MR; de Vries E; Valentijn RM; Cats A
J Rheumatol; 1985 Jun; 12(3):449-55. PubMed ID: 4045842
[TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of complement-fixing rheumatoid synovial fluid immune complexes.
Male DK; Roitt IM
Clin Exp Immunol; 1981 Dec; 46(3):521-9. PubMed ID: 7337979
[TBL] [Abstract][Full Text] [Related]
12. C1 inactivator-C1s complexes in inflammatory joint disease.
Inman RD; Harpel PC
Clin Exp Immunol; 1983 Sep; 53(3):521-8. PubMed ID: 6604603
[TBL] [Abstract][Full Text] [Related]
13. Complement C3c and C3d in plasma and synovial fluid in rheumatoid arthritis.
Berkowicz A; Kappelgaard E; Petersen J; Nielsen H; Ingemann-Hansen T; Halkjaer-Kristensen J; Sørensen H
Acta Pathol Microbiol Immunol Scand C; 1983 Dec; 91(6):397-402. PubMed ID: 6608857
[TBL] [Abstract][Full Text] [Related]
14. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
[TBL] [Abstract][Full Text] [Related]
15. [Demonstration and analysis of immune complexes in rheumatic diseases].
Rosenthal M; Graf U; Müller W
Schweiz Med Wochenschr; 1976 Aug; 106(33):1116-21. PubMed ID: 1087456
[TBL] [Abstract][Full Text] [Related]
16. Immune complex detection and complement activity in rheumatoid arthritis: a comparative study of a radioimmunoassay using monoclonal rheumatoid factor, gel diffusion techniques and C4 activity.
Halla JT; Volanakis JE; Hardin JG; Schrohenloher RE
Clin Exp Immunol; 1978 Nov; 34(2):226-34. PubMed ID: 737907
[TBL] [Abstract][Full Text] [Related]
17. [Is the demonstration of immune complex useful in the activity assessment of chronic polyarthritis?].
Schlumpf U; Ernst R; Christen P; von Felten A; Böni A
Schweiz Med Wochenschr; 1984 Jan; 114(4):118-30. PubMed ID: 6367028
[TBL] [Abstract][Full Text] [Related]
18. [Influence of lysozyme on the circulating level of immune complexes in patients with rheumatoid arthritis].
Di Matteo L; Bosica D; Consoli G; Anichini M
Boll Soc Ital Biol Sper; 1985 May; 61(5):783-6. PubMed ID: 3875357
[No Abstract] [Full Text] [Related]
19. Demonstration of C1q - binding to collagen - anticollagen immune complexes in synovial fluids of RA-patients.
Menzel J; Steffen C
Z Rheumatol; 1982; 41(2):47-9. PubMed ID: 6285637
[TBL] [Abstract][Full Text] [Related]
20. Activation of complement components C3 and factor B in synovial fluids.
Hunder GG; McDuffie FC; Mullen BJ
J Lab Clin Med; 1977 Jan; 89(1):160-71. PubMed ID: 830776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
